TNGX
Tango Therapeutics, Inc.
Healthcare •
Biotechnology •
stocks •
XNAS
• usd
$12.32
$-0.23
(-1.83%)
Loading...
SMA 20: -
SMA 50: -
SMA 200: -
| General | Valuation | Profitability | Financial Health | Trading | Ownership |
|---|---|---|---|---|---|
| Market Cap | $1.66B | EPS (ttm) | $-0.91 | Current Price | $12.32 |
| Enterprise Value | $1.54B | Forward EPS | $-1.29 | Previous Close | $12.55 |
| P/E Ratio | - | ROA | -24.52% | 52W High | $13.46 |
| Forward P/E | -9.52 | ROE | -51.65% | 52W Low | $1.03 |
| PEG Ratio | - | Gross Margin | -101.50% | 50 Day Avg | $10.28 |
| P/S Ratio | 24.95 | Operating Margin | 26.15% | 200 Day Avg | $6.87 |
| P/B Ratio | 8.59 | Profit Margin | -151.15% | Volume | 2.21M |
| EV/EBITDA | -14.27 | Current Ratio | 8.88 | Avg Volume | 3.00M |
| EV/Sales | 23.16 | Quick Ratio | 8.29 | Beta | 1.76 |
| Employees | 155.00 | Debt/Equity | 21.72 | Shares Outstanding | 134.68M |
| Sector | Healthcare | Total Debt | $34.76M | Float Shares | 80.16M |
| Industry | Biotechnology | Total Cash | $152.81M | Short Float | 36.81% |
| Optionable | Yes | Cash/Share | $1.14 | Short Ratio | 13.07 |
| Dividend Yield | - | Book Value/Share | $1.43 | % Held by Insiders | 4.95% |
| Target Price | $13.62 | Revenue (TTM) | $66.50M | % Held by Institutions | 99.39% |